High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II
- PMID: 35327422
- PMCID: PMC8945336
- DOI: 10.3390/biomedicines10030620
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II
Abstract
The notion that high-density lipoproteins (HDL) are atheroprotective is supported by different lines of evidence [...].
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the development of this Special Issue, in the writing of this manuscript, or in the decision to publish it.
Similar articles
-
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.Molecules. 2018 Oct 23;23(11):2730. doi: 10.3390/molecules23112730. Molecules. 2018. PMID: 30360466 Free PMC article. Review.
-
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future.Int J Mol Sci. 2021 Jul 13;22(14):7488. doi: 10.3390/ijms22147488. Int J Mol Sci. 2021. PMID: 34299108 Free PMC article.
-
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future.Biomedicines. 2021 Jul 22;9(8):857. doi: 10.3390/biomedicines9080857. Biomedicines. 2021. PMID: 34440061 Free PMC article.
-
[The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases].Ter Arkh. 2016;88(9):111-118. doi: 10.17116/terarkh2016889111-118. Ter Arkh. 2016. PMID: 28635814 Review. Russian.
-
Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).Int J Mol Sci. 2013 May 10;14(5):10107-21. doi: 10.3390/ijms140510107. Int J Mol Sci. 2013. PMID: 23665908 Free PMC article.
Cited by
-
Excessive Consumption of Alcoholic Beverages and Extremely High Levels of High-Density Lipoprotein Cholesterol (HALP) in the ELSA-Brasil Cohort Baseline.Nutrients. 2023 Feb 28;15(5):1221. doi: 10.3390/nu15051221. Nutrients. 2023. PMID: 36904219 Free PMC article.
References
-
- Kanbay M., Solak Y., Unal H.U., Kurt Y.G., Gok M., Cetinkaya H., Karaman M., Oguz Y., Eyileten T., Vural A., et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int. Urol. Nephrol. 2014;46:1619–1625. doi: 10.1007/s11255-014-0730-1. - DOI - PubMed
-
- Coimbra S., Reis F., Valente M.J., Rocha S., Catarino C., Rocha-Pereira P., Sameiro-Faria M., Bronze-da-Rocha E., Belo L., Santos-Silva A. Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease? Biomedicines. 2021;9:554. doi: 10.3390/biomedicines9050554. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials